AAAAAA
Results:
1-7
|
Results: 7
Authors:
TENERO D
MARTIN D
CHAPELSKY M
ILSON B
BOIKE S
PATTERSON S
KEOGH J
RODRIGUEZ S
JORKASKY D
Citation: D. Tenero et al., EFFECT OF HEPATIC-DISEASE ON THE PHARMACOKINETICS AND PLASMA-PROTEIN BINDING OF EPROSARTAN, Pharmacotherapy, 18(1), 1998, pp. 42-50
Authors:
TENERO D
MARTIN D
ILSON B
JUSHCHYSHYN J
BOIKE S
LUNDBERG D
ZARIFFA N
BOYLE D
JORKASKY D
Citation: D. Tenero et al., PHARMACOKINETICS OF INTRAVENOUSLY AND ORALLY-ADMINISTERED EPROSARTAN IN HEALTHY-MALES - ABSOLUTE BIOAVAILABILITY AND EFFECT OF FOOD, Biopharmaceutics & drug disposition, 19(6), 1998, pp. 351-356
Authors:
MARTIN DE
CHAPELSKY MC
ILSON B
TENERO D
BOIKE SC
ZARIFFA N
JORKASKY DK
Citation: De. Martin et al., PHARMACOKINETICS AND PROTEIN FINDING OF EPROSARTAN IN HEALTHY-VOLUNTEERS AND IN PATIENTS WITH VARYING DEGREES OF RENAL IMPAIRMENT, Journal of clinical pharmacology, 38(2), 1998, pp. 129-137
Authors:
MARTIN DE
TOMPSON D
BOIKE SC
TENERO D
ILSON B
CITERONE D
JORKASKY DK
Citation: De. Martin et al., LACK OF EFFECT OF EPROSARTAN ON THE SINGLE-DOSE PHARMACOKINETICS OF ORALLY-ADMINISTERED DIGOXIN IN HEALTHY MALE-VOLUNTEERS, British journal of clinical pharmacology, 43(6), 1997, pp. 661-664
Authors:
KAZIERAD DJ
MARTIN DE
TENERO D
BOIKE SC
ILSON B
FREED MI
ETHEREDGE R
JORKASKY DK
Citation: Dj. Kazierad et al., FLUCONAZOLE(F) SIGNIFICANTLY ALTERS THE PHARMACOKINETICS (PK) OF LOSARTAN(L) BUT NOT EPROSARTAN(E), Clinical pharmacology and therapeutics, 61(2), 1997, pp. 35-35
Authors:
TENERO D
ILSON B
BOYLE D
BOIKE S
ZARIFFA N
BROZENA S
FESNIAK H
JORKASKY D
Citation: D. Tenero et al., DOSE-PROPORTIONAL STEREOSELECTIVE KINETICS OF CARVEDILOL IN PATIENTS WITH CHF, Clinical pharmacology and therapeutics, 59(2), 1996, pp. 54-54
Authors:
ILSON B
TENERO D
KNOX S
BOIKE S
AUDET P
FREED M
EVERITT D
BROWN L
BOYLE D
JORKASKY D
Citation: B. Ilson et al., FOOD SIGNIFICANTLY INCREASES THE ORAL BIOAVAILABILITY OF SK-AND-F, Clinical pharmacology and therapeutics, 55(2), 1994, pp. 168-168
Risultati:
1-7
|